Our Board of Directors is entrusted with the responsibility for the overall management of our Group. Information on the business and working experience of our Directors are set out below:
Dr Chin Pak Lin
Executive Director & Chief Executive Officer
Medical Specialist: Orthopaedic Surgery
Special Interest: Hip and Knee
Dr Chin Pak Lin is the Executive Director and Chief Executive Officer (“CEO“) and was first appointed to the Board on 27 September 2017, and was last re-elected on 28 January 2019. Dr Chin was one of the founding members of The Orthopaedic Centre and has been a Medical Specialist with the Group since 2013. In addition to his role as a medical specialist, Dr Chin has been actively managing the Group as the CEO and making executive decisions at the Group level in relation to the operations and business direction of the Group.
Dr Chin graduated from National University of Singapore (“NUS“) with a Bachelor of Medicine and Bachelor of Surgery in 1998 and subsequently obtained his Masters of Medicine in Orthopaedic Surgery in 2003 from the Graduate School of Medical Studies, NUS. In 2007, Dr Chin qualified for his fellowship in Orthopaedic Surgery with the Royal College of Surgeons of Edinburgh, United Kingdom and in 2008, Dr Chin received the Health Manpower Development Programme scholarship from MOH to pursue advance training in joint replacement at the Manchester Royal Infirmary, United Kingdom.
Dr Chin has previously held various appointments such as, inter alia, a Director of the Musculoskeletal Bone Bank, an Adjunct Assistant Professor at Duke-NUS Graduate Medical School and a consultant to the Stryker Knee Navigations, Zimmer Knee Arthroplasty and to the Department of Orthopaedic Surgery, Singapore General Hospital (“SGH“).
As an active volunteer in medical missions, Dr Chin has participated in the Pakistan Earthquake Medical Mission Trip under SingHealth and Cambodia Medical Mission Specialist Programme in Calmette Hospital in Phnom Penh under Singapore International Foundation.
Dr Yue Wai Mun
Executive Director & Chief Medical Officer
Medical Specialist: Orthopaedic Surgery
Special Interest: Spine
Dr Yue Wai Mun is an Executive Director and the Chief Medical Officer (“CMO”) of the Group and was first appointed to the Board on 27 September 2017, and was last re-elected on 23 January 2020. Dr Yue joined the Group as a medical specialist with a special interest in spine and scoliosis surgery in 2015 and is presently an Adjunct Associate Professor at the Duke-NUS Graduate Medical School and Clinical Senior Lecturer at NUS.
Dr Yue graduated with a Bachelor of Medicine and Bachelor of Surgery in 1992 from NUS and was admitted as a Fellow of the Royal College of Surgeons of Edinburgh in 1998. He became a Fellow of the Academy of Medicine (Orthopaedic Surgery) in 2004.
From 2009 to 2015, Dr Yue was a Senior Consultant in the Spine Service of the Department of Orthopaedic Surgery, SGH. He held a concurrent post as the Director of the Spine Fellowship Programme and Director of Quality Assurance and Clinical Governance. Further, Dr Yue was on the Master of Medicine (Orthopaedic) Committee and remains an examiner for the Joint Specialty Fellowship Examination in Orthopaedic Surgery, Master of Medicine Examination in both Orthopaedic Surgery and Family Medicine and the Bachelor of Medicine and Bachelor of Surgery Examination in NUS.
Dr Cheng Ching Li, Bobby
Medical Specialist: Ophthalmology
Special Interest: Vitreoretinal Medicine
Dr Cheng Ching Li, Bobby is an Executive Director of the Group and was first appointed to the Board on 19 February 2020. Dr Cheng joined the Group as a medical specialist and head of the Group’s Ophthalmology division. He is a senior ophthalmic surgeon in Cataract and Comprehensive Ophthalmology, with special interest in the fields of vitreoretinal medicine and surgery as well as uveitis.
Prior to joining, Dr Cheng was one of the founding members of Cornerstone Asia Health Pte. Ltd. (“CAH”), since 2017. Prior to CAH, Dr Cheng started private medical specialist practice in 2008 specialising in Ophthalmology. He graduated from the National University of Singapore with a Bachelor of Medicine, Bachelor of Surgery in 1993 before going on to specialise in the field of Ophthalmology. He was also admitted as a Fellow of the Royal College of Surgeons of Edinburgh in 2000 and a fellow of the Academy of Medicine (Singapore) in 2008.
Mr Leow Chung Chong Yam Soon
Non-Executive Chairman/Independent Director
Mr Leow Chung Chong Yam Soon is a Non-Executive Chairman and Independent Director of the Company and was first appointed to the Board on 28 March 2018, and was last re-elected on 28 January 2019. Mr Leow is presently a partner in Ecovis Assurance LLP as well as a Director of Ecovis Advisory Pte. Ltd. and Spring & Associates PAC. Prior to that he was an audit partner with Deloitte & Touche LLP. Mr Leow has more than 20 years of accounting and financial audit experience. Mr Leow is currently an Independent Director of Fragrance Group Limited, a company listed on the Main Board of the SGX-ST and an Independent Director of No Signboard Holdings Ltd., a company listed on the Catalist.
He is a practicing member of the Institute of Singapore Chartered Accountants (ISCA). He is also a Fellow Chartered Association of Certified Accountants, UK and Certified Public Accountants, USA.
Mr Siek Wei Ting, Ryan
Mr Siek Wei Ting, Ryan is an Independent Director of the Company and was first appointed to the Board on 28 March 2018, and was last re-elected on 28 January 2019. Mr Siek is presently the Finance Director of V3 Group Pte Ltd. He is concurrently a Non-Executive Director of China Minzhong Food Corporation Pte. Ltd., a company formerly listed on the Main Board of the SGX-ST.
Prior to joining China Minzhong Food Corporation Pte. Ltd., Mr Siek was the Head of Operations Group, Southern Bank Berhad from 2002 to 2004 and a Director and Chief Executive Officer of EBBiS Pte Ltd from 1999 to 2001.
Mr Siek worked as an audit supervisor for Ernst & Young LLP from 2001 to 2002 and for Deloitte & Touche LLP from 1996 to 1999. He graduated with a Bachelor of Accountancy from the Nanyang Technological University in 1996.
Mr Vikram Nair
Mr Vikram Nair is an Independent Director of the Company and was first appointed to the Board on 28 March 2018, and was last re-elected on 23 January 2020. He is presently a partner at Rajah & Tann Singapore LLP and heads its India desk and is also a Member of Parliament for the Sembawang Group Representation Constituency.
Mr Nair is qualified in both Singapore and English law and has more than 13 years of experience as a practicing lawyer specializing in international arbitration and commercial and corporate litigation, with particular experience in handling complex, multi-jurisdictional disputes in services such as banking, finance, oil & gas, manufacturing, mining, construction and property development.
Prior to commencing legal practice, Mr Nair was a management consultant at McKinsey & Company from 2002 to 2004.
Mr Nair graduated with a Bachelor of Arts with Honours in law from the University of Cambridge.
Mr Yeo Wee Kiong
Non-Executive and Non-Independent Director
Mr Yeo Wee Kiong is a Non-Executive and Non- Independent Director of the Company and was first appointed to the Board on 3 September 2020. He has had more than 22 years of practice experience as a corporate finance lawyer and has retired since 2012. Prior to that, he was an investment banker with a Singapore-based UK merchant bank and a senior industry officer with a government statutory board.
He is currently a member of the board of Heliconia Capital Management Pte Ltd, a subsidiary of Temasek Holdings.
Mr Yeo holds a Bachelor of Engineering (First Class Honours) degree from the University of Singapore, a Bachelor of Laws (Honours) degree from the University of London, and a Master of Business Administration degree from the National University of Singapore.